You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 15, 2021

Hemp Now Legally Permitted for Use in Cosmetics in Thailand

Following the recent delisting of almost all parts of the hemp plant from Thailand’s list of prohibited narcotics (see here for further details), the Ministry of Public Health has issued a notification allowing hemp to be used in cosmetics. Prior to this development, this use of hemp (whether from natural or synthetic sources) was not allowed, as it fell under the definition of narcotics under the Notification Re: Ingredients Not Allowed for Use in Cosmetics B.E. 2559 (2016).

Under the Ministerial Notification Re: Use of Hemp in Cosmetics B.E. 2564 (2021), which was published in the Government Gazette on January 11, 2021, domestic manufacturers are now allowed to produce cosmetics containing hemp seed oil or hemp seed extract, provided the cosmetics do not have a THC level exceeding 0.2% by weight.

To register such products with the Thai FDA, applicants must submit a certificate of analysis, safety data sheet, and label for the agency’s evaluation. The timeline for approval of the registration (notification) of a cosmetic containing hemp seed oil or hemp seed extract is three business days. The applicant (i.e., manufacturer or toll manufacturer) must declare the amount of hemp seed extract or hemp seed oil used in the cosmetic in their notification application. Cosmetics must not use a name for the product that evokes an association with hemp flowers or narcotics, and the name of the product must be within the scope of cosmetics. For example, names containing “inflorescence,” “flower,” “CBD,” “THC” or similar will not be allowed.

It should also be noted that Thailand does not yet allow the importation of cosmetics containing hemp seeds or hemp seed extract, and this regulation only applies to domestically produced hemp products—a business currently restricted to individuals or companies with Thai nationality.

For more details on this development, or on any aspect of hemp and cannabis regulations in Thailand, please contact Tilleke & Gibbins at [email protected].

RELATED INSIGHTS​ 

November 28, 2017
The private sector in Indonesia has been vocal about their concern for the government’s plan to make halal certification mandatory, believing that this requirement will add a greater burden to their business. Amid criticism, the government is moving forward with its halal assurance system, citing, among other reasons, the need for a government agency to be the new halal certification authority to create greater transparency in the existing certification process.Halal Regulators
October 31, 2017
Foodpedia articles, published online on the ChemLinked Chemical Portal by REACH24H Consulting Group, provide an overview of the food industries in eight jurisdictions in Asia. An article on Food Regulation in Thailand, written by Alan Adcock, a partner and deputy director of the intellectual property and regulatory affairs group at Tilleke & Gibbins, provides an overview of the following subjects:
September 21, 2017
PLC Life Sciences Global Guide  is a Q&A-style chapter that provides an overview of the regulatory frameworks of the life sciences industries across multiple jurisdictions worldwide. Legal practitioners from Tilleke & Gibbins contributed to the Thailand chapter of the guide, which is comprised of the following two sections:Medical Product Regulation and Product Liability in Thailand
September 21, 2017
Pharmaceutical experts from Tilleke & Gibbins authored the Vietnam chapters of the latest edition of the PLC Life Sciences Global Guide. PLC’s popular guides provide a comparative overview, in Q&A format, of laws and regulations across a wide range of practice areas in dozens of jurisdictions around the world.The Life Sciences Global Guide  focuses on the pharmaceutical sector and related areas, and is divided into two sections. The first section covers medicinal product regulation and product liability, including the following topics: